Human Metabolic Research Unit
Ithaca, New York, 14850, United States
NCT Number: NCT05248737
The purpose of the research is to evaluate if chicken or eggs obtained from chickens that are fed a diet that contains omega-3 fatty acids (DHA/EPA), or vitamin D (as 25(OH)D) provides additional health benefits by improving the status of omega-3 fatty acids or 25(OH)D in healthy adults who eat this bioenhanced chicken or eggs.
This study is active but is not currently recruiting participants.
Notify Me18 year–35 year
All sexes
Observational
Ithaca, New York, 14850, United States
The 2015-2020 Dietary Guidelines advocate intake of lean proteins (such as chicken and fish) while limiting intake of saturated fat. Chicken contains similar protein to beef or pork but has less saturated fat. However, chicken, like other terrestrial meats, has little omega-3 polyunsaturated fatty acids such as docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) and relatively little vitamin D. Vitamin D insufficiency is common in the US and globally, and has been linked to a number of adverse health outcomes. Vitamin D is ingested primarily from fortified dairy products, but recent animal studies have increased the D content of pork and beef, and the DHA content of chicken and of eggs produced from bioenhanced chickens. Moreover, sunlight exposure alone can enhance the 25(OH)D content of chicken. Notably, supplemental 25(OH)D is more effective than vitamin D at improving vitamin D status in humans, but little is known about the bioavailability of 25(OH)D or DHA/EPA enhanced chicken (muscle) or in enhanced eggs produced from supplemented chickens.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For participants who received DHA/EPA fortified chicken
Provided to participants in the group where they consumed non-fortified chicken/eggs
Used in the crossover part of the study given to the group who did not received DHA bio-enhanced chicken
participants will receive 25(OH)D bioenhanced chicken and eggs plus a placebo as a dietary intervention
For the participants who received DHA/EPA fortified eggs
for the participants who received non-DHA bio-enhanced eggs plus supplement DHA Omega-3
Provided to participants in the group where they consumed non-fortified chicken/eggs + placebo pills
Time frame: Baseline, and time course of 1 hour, 2 hour, 4 hour and 8 hour post meal
Measuring plasma DHA concentration across different time points to assess DHA bioavailability and absorption
Time frame: Baseline, and time course of week 2, week 4, week 6, week 8
Measuring serum 25(OH)D concentration across different time points to assess 25(OH)D bioavailability and absorption
Cornell University
Other
Empowering and Transforming the US Broiler Production for Growth, Profit and Sustainability
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05659966
Behavior, Behavior, Animal
Columbia, South Carolina, United States
View Trial DetailsNCT05776303
Behavior, Behavior, Animal
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05820256
Nutrition, Healthy
Guelph, Ontario, Canada
View Trial DetailsNCT05399667
Early Intervention, Female Urogenital Diseases and Pregnancy Complications
Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details